Results 161 to 170 of about 5,953 (226)

Influence of antiviral treatment in hepatitis C patients on metabolism and fibrosis process. [PDF]

Front Med (Lausanne)
Jędrysik M, Tomasiewicz K, Chełstowska B, Tudrujek-Zdunek M, Szymański FM.   +4 more
europepmc   +1 more source

Repurposing antiviral agents against mucormycosis. [PDF]

PLoS One
Khan AA, AlKashef NM, Seleem MN.
europepmc   +1 more source

Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis [PDF]

, 2016
Da-Zhi Zhang, Qiong-Fang Zhang, Qiu-Feng He   +2 more
core   +1 more source

Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting. [PDF]

Eur J Clin Microbiol Infect Dis
Pokorska-Śpiewak M, Dobrzeniecka A, Talarek E, Aniszewska M, Marczyńska M.   +4 more
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India [PDF]

, 2019
Ajit Sood, Ajay Duseja, Mayank Kabrawala, Pradeep Amrose, Bhadadev Goswami, Abhijit Chowdhury, Shiv Kumar Sarin, Abraham Koshy, Robert H. Hyland, Sophia Lu, Grégory Camus, Luisa M. Stamm, Diana M. Brainard, G. Mani Subramanian, M. N. Giri Prasad, Shobna Bhatia, Samir R. Shah, Dharmesh Kapoor, S. Shalimar, Vivek A. Saraswat   +19 more
openalex   +1 more source

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients [PDF]

, 2019
Angeletti, Silvia, Calogero, Armando, Candida, Maria, Carlomagno, Nicola, Ciccozzi, Massimo, Creta, Massimiliano, Dodaro, CONCETTA ANNA, Incollingo, Paola, Minieri, Gianluca, Peluso, Gaia, Sagnelli, Caterina, Sagnelli, Evangelista   +11 more
core   +1 more source

Community-based integrated care for HIV, viral hepatitis and sexually transmitted infections, Thailand. [PDF]

Bull World Health Organ
Wansom T, Thongmee A, Chittmittrapap S, Saraporn T, Chavalertsakul K, Chotirosniramit N, Pattarakijroongrueng S, Palakawong Na Ayuthaya T, Verachai V, Traisirichok P, Intharabut B, Linn N, Teuansiri R, Kulprayong K, Waesateh A, Lawseng S, Chumwangwapee T, Pattarasuteewong S, Pudpong N, Unchit D, Photipap J, Wongsuwon C, Werapattanawong N, Smahoh S, Sae-Chee P, Phueakchai S, Kittikoonprasert P, Bootsan P, Lawpoolsri S, Creac'H P, Mills S, Yoocharoen P, Avihingsanon A, Phanuphak N, Riewpaiboon A, Durier N, C-Free Study Group..   +36 more
europepmc   +1 more source

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis [PDF]

, 2018
Rafael Esteban, Juan A. Pineda, José Luís Calleja, Marta Casado, Manuel Rodríguez, Juan Turnés, Luís Morano, Rosa M. Morillas, Xavier Forns, Juan Manuel Pascasio Acevedo, Raúl J. Andrade, Antonio Rivero, J.A. Carrión, Sabela Lens, Mar Riveiro‐Barciela, Brian McNabb, Gulan Zhang, Grégory Camus, Luisa M. Stamm, Diana M. Brainard, G. Mani Subramanian, Marı́a Buti   +21 more
openalex   +1 more source

Pharmacokinetics of Sofosbuvir and Velpatasvir for Hepatitis C Treatment in Pregnancy. [PDF]

Biomedicines
Giles ML, Dunbar A, Krishnaswamy S, Sasadeusz J, Said JM, Roon L, Bushman LR, Brooks KM.   +7 more
europepmc   +1 more source